Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $54.7 million.

  • Orthopediatrics' Operating Expenses rose 1989.22% to $54.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.2 million, marking a year-over-year increase of 2338.89%. This contributed to the annual value of $183.6 million for FY2024, which is 3304.54% up from last year.
  • Latest data reveals that Orthopediatrics reported Operating Expenses of $54.7 million as of Q3 2025, which was up 1989.22% from $54.7 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Operating Expenses ranged from a high of $54.7 million in Q3 2025 and a low of $22.2 million during Q3 2021
  • Over the past 5 years, Orthopediatrics' median Operating Expenses value was $34.8 million (recorded in 2023), while the average stood at $36.2 million.
  • Per our database at Business Quant, Orthopediatrics' Operating Expenses crashed by 1514.3% in 2021 and then soared by 4798.63% in 2022.
  • Orthopediatrics' Operating Expenses (Quarter) stood at $23.6 million in 2021, then grew by 24.92% to $29.5 million in 2022, then rose by 17.77% to $34.8 million in 2023, then skyrocketed by 42.67% to $49.6 million in 2024, then increased by 10.24% to $54.7 million in 2025.
  • Its Operating Expenses was $54.7 million in Q3 2025, compared to $54.7 million in Q2 2025 and $49.2 million in Q1 2025.